Cargando…
Is colchicine the holy grail for treating inflammation and reducing cardiovascular risk?
Autores principales: | Filipiak, Krzysztof J., Surma, Stanisław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790102/ https://www.ncbi.nlm.nih.gov/pubmed/35112118 http://dx.doi.org/10.1016/j.ijcrp.2021.200106 |
Ejemplares similares
-
Evinacumab – The new kid on the block. Is it important for cardiovascular prevention?
por: Surma, Stanisław, et al.
Publicado: (2021) -
The Holy grail, genes and Number Needed to Treat
por: Herbert, Mel
Publicado: (2007) -
First Sips From the Holy Grail?
por: Kawai, Tatsuo
Publicado: (2023) -
Is tissue Doppler echocardiography the Holy Grail for the intensivist?
por: Poelaert, Jan, et al.
Publicado: (2007) -
Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification?
por: Bazarbashi, Ahmad Najdat, et al.
Publicado: (2021)